Endometrial Cancer Trial, Recruiting (NCT07461818)

Endometrial Cancer Trial, Recruiting NCT07461818 Sponsor: Basic Health International, Inc. Condition: Endometrial Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07461818 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometrial Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women between the ages of 30 and 49 years old
People who are not currently pregnant, confirmed by a urine pregnancy test
People whose HPV-positive status is recorded in Ministry of Health records
People who are willing to have a colposcopy (a close examination of the cervix) and tissue samples taken
People who are able and willing to sign a consent form agreeing to take part

Who may not be able to join:

People who are planning to become pregnant during the study period
People who have had a LEEP procedure or a cervical ablation treatment within the past 5 years (these are procedures used to remove or destroy abnormal cervical tissue)
People who have had a total hysterectomy (surgery to remove the entire uterus and cervix), confirmed by medical records or a physical examination
People who have a history of cervical cancer
People who are unable or unwilling to provide a permanent and reliable home address
People who are unable or unwilling to sign a consent form agreeing to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Karla Alfaro, MD, Basic Health International, Inc.

Phone: +503 22838731

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07461818

Sponsor: Basic Health International, Inc.

Phase: Not Applicable

Status: Recruiting

Condition: Endometrial Cancer

Trial contact: +503 22838731

More information: https://clinicaltrials.gov/study/NCT07461818

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women between the ages of 30 and 49 years old
People who are not currently pregnant, confirmed by a urine pregnancy test
People whose HPV-positive status is recorded in Ministry of Health records
People who are willing to have a colposcopy (a close examination of the cervix) and tissue samples taken
People who are able and willing to sign a consent form agreeing to take part

Who may not be able to join:

People who are planning to become pregnant during the study period
People who have had a LEEP procedure or a cervical ablation treatment within the past 5 years (these are procedures used to remove or destroy abnormal cervical tissue)
People who have had a total hysterectomy (surgery to remove the entire uterus and cervix), confirmed by medical records or a physical examination
People who have a history of cervical cancer
People who are unable or unwilling to provide a permanent and reliable home address
People who are unable or unwilling to sign a consent form agreeing to take part

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Basic Health International, Inc.

Registry

ClinicalTrials.gov

Start date

1 March 2026

Est. completion

1 January 2029

Where this trial is recruiting

El Salvador

Primary endpoints

1-Year Cure Rate of CIN2+

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov